Form 4 for MRNA Moderna
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-28 · accession 0001127602-25-007550 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-03 | 2025-02-28 | MRNA | Mock James M | CFO | M - OptEx | — | +329 | 15.0K | +2% | — |
| D | 2025-03-03 | 2025-02-28 | MRNA | Mock James M | CFO | F - Tax | $31.09 | -160 | 14.9K | -1% | -$4,974 |
| DM | 2025-03-03 | 2025-03-01 | MRNA | Mock James M | CFO | A - Grant | $0.00 | +103.1K | 63.5K | New | $0 |
| D | 2025-03-03 | 2025-02-28 | MRNA | Mock James M | CFO | M - OptEx | $0.00 | -329 | 2,630 | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-28 | M | A | 329 | — | 15,034 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2025-02-28 | F | D | 160 | $31.09 | 14,874 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-03-01 | A | A | 39,606 | $0.00 | 39,606 | D | — · — to — | 39,606 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F5) 25% of the shares subject to this restricted stock unit award will vest on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 4 | Derivative | Restricted Stock Units | 2025-02-28 | M | D | 329 | $0.00 | 2,630 | D | — · — to — | 329 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-03-01 | A | A | 63,478 | $0.00 | 63,478 | D | $30.96 · 2026-03-01 to 2035-03-01 | 63,478 Common Stock | (F4) 25% of this option will vest and become exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |